Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

On this episode of Aging Untold, we’re decoding Medicare Part B, including what it is and what it covers. Plus, we’ll discuss ...

Coverage of several self-administered DMARDs declined across Medicare Part D plans between 2022 and 2026, with differential coverage noted across plan types.

Don't let yourself get caught off guard.

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. On November 14, the Centers for Medicare and Medicaid ...

There's a reason many older workers push themselves to remain employed until they turn 65. Age 65 is when Medicare eligibility generally begins. And without Medicare or employer-subsidized insurance, ...

Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and how to avoid costly surprises.

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...

The AHA today submitted comments on the Centers for Medicare & Medicaid Services’ proposed revisions to Medicare Advantage and Part D reporting requirements for contract year 2027. The new ...

Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...

The Medicare agency will extend a short-term program that will pay for weight-loss drugs such as Eli Lilly’s Zepbound and Novo Nordisk’s NOVO.B-1.76%decrease; red down pointing triangle Wegovy, ...